Charles Schwab Investment Management Inc I Teos Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 199,196 shares of ITOS stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

199,196

Previous 222,135 10.33%

Holding current value

$1.47 Million

Previous $2.27 Million 32.55%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$7.22 - $10.02 $165,619 - $229,848	-22,939 Reduced 10.33%	199,196 $1.53 Million
Q3 2024 Nov 12, 2024	BUY	$10.09 - $17.97 $84,725 - $150,894	8,397 Added 3.93%	222,135 $2.27 Million
Q2 2024 Aug 12, 2024	BUY	$10.33 - $18.09 $81,328 - $142,422	7,873 Added 3.82%	213,738 $3.17 Million
Q1 2024 May 08, 2024	BUY	$9.89 - $13.64 $42,675 - $58,856	4,315 Added 2.14%	205,865 $2.81 Million
Q4 2023 Feb 06, 2024	SELL	$8.57 - $11.06 $73,881 - $95,348	-8,621 Reduced 4.1%	201,550 $2.21 Million
Q3 2023 Nov 08, 2023	BUY	$10.95 - $14.6 $210,875 - $281,166	19,258 Added 10.09%	210,171 $2.3 Million
Q2 2023 Aug 09, 2023	BUY	$12.93 - $18.05 $102,754 - $143,443	7,947 Added 4.34%	190,913 $2.53 Million
Q1 2023 May 11, 2023	BUY	$13.02 - $22.62 $6,210 - $10,789	477 Added 0.26%	182,966 $2.49 Million
Q4 2022 Feb 13, 2023	BUY	$17.77 - $21.6 $76,801 - $93,355	4,322 Added 2.43%	182,489 $3.56 Million
Q3 2022 Nov 14, 2022	BUY	$18.6 - $27.25 $507,556 - $743,598	27,288 Added 18.09%	178,167 $3.39 Million
Q2 2022 Aug 15, 2022	BUY	$16.57 - $35.1 $85,004 - $180,063	5,130 Added 3.52%	150,879 $3.11 Million
Q1 2022 May 13, 2022	BUY	$31.92 - $47.45 $101,314 - $150,606	3,174 Added 2.23%	145,749 $4.69 Million
Q4 2021 Feb 11, 2022	BUY	$26.23 - $47.86 $53,955 - $98,448	2,057 Added 1.46%	142,575 $6.64 Million
Q3 2021 Nov 16, 2021	BUY	$23.91 - $29.58 $1.04 Million - $1.28 Million	43,432 Added 44.74%	140,518 $3.79 Million
Q2 2021 Aug 16, 2021	BUY	$17.9 - $36.1 $60,394 - $121,801	3,374 Added 3.6%	97,086 $2.49 Million
Q1 2021 May 17, 2021	BUY	$30.86 - $44.2 $585,136 - $838,076	18,961 Added 25.37%	93,712 $3.2 Million
Q4 2020 Feb 16, 2021	BUY	$21.59 - $33.95 $121,119 - $190,459	5,610 Added 8.11%	74,751 $2.53 Million
Q3 2020 Nov 13, 2020	BUY	$17.57 - $32.92 $1.21 Million - $2.28 Million	69,141 New	69,141 $1.71 Million

Others Institutions Holding ITOS

# of Institutions

150

Shares Held

37M

Call Options Held

1.63M

Put Options Held

1.96M

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $263M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc I Teos Therapeutics, Inc. Transaction History